What did Veradermics report about its oral minoxidil pill for female hair loss?

Veradermics announced that its oral minoxidil candidate for female pattern hair loss showed stronger-than-expected results in a Phase 2 trial. The company said this could become the first pill specifically approved for that indication, boosting its share price to around $130 and highlighting the potential for a new, targeted treatment option.